apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
Insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. SURVANTA INJECTION 8ML

SURVANTA INJECTION 8ML, Pack of 1 Injection
Non returnable*
Know More
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

BERACTANT-25MG

Manufacturer/Marketer :

Abbott India Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About SURVANTA INJECTION 8ML

SURVANTA INJECTION 8ML belongs to a class of drugs called pulmonary surfactants. It is used in the treatment/prevention of premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient lung surfactant.

SURVANTA INJECTION 8ML contains Beractant, a natural surfactant that acts similarly to the baby's own surfactant, helping your baby to breathe normally. It will help your baby breathe normally until it produces its own surfactant.

SURVANTA INJECTION 8ML will be given to your baby in a hospital by a suitably trained doctor. Sometimes, SURVANTA INJECTION 8ML may cause a slow heart rate, endotracheal tube blockage, and low blood oxygen levels. Talk to the doctor if you have any concerns.

The administration of SURVANTA INJECTION 8ML to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby has any problems while being treated with SURVANTA INJECTION 8ML, consult your doctor as soon as possible, even if you do not know the condition is related to the medicine.

Uses of SURVANTA INJECTION 8ML

Respiratory distress syndrome (RDS)

Directions for Use

SURVANTA INJECTION 8ML will be given to your baby in a hospital by a trained healthcare professional. SURVANTA INJECTION 8ML should be administered via the endotracheopulmonary route. It should only be administered with adequate facilities for ventilation and monitoring babies with RDS (respiratory distress syndrome).

Medicinal Benefits

SURVANTA INJECTION 8ML contains Beractant as a natural surfactant. SURVANTA INJECTION 8ML is used to treat respiratory distress syndrome (RDS) in newborn premature infants weighing 700 g or more at delivery. It is also used to treat premature babies who are in danger of developing RDS and require a tube put into their windpipe for stabilisation or who have indications of surfactant deficiency. It functions similarly to your baby's own surfactant, assisting your infant in breathing healthily. It will allow your infant to breathe normally until his or her own surfactant is produced.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Before using SURVANTA INJECTION 8ML, make sure the doctor knows your child's medical conditions, sensitivities, and medications. Occasionally, episodes of slow heartbeat (bradycardia) and/or oxygen deficiency in the circulation have been reported during the dosing procedure. If these occur, dosing will be discontinued, and appropriate measures to relieve the condition will be initiated. The dosing procedure will be restarted once the individual has been stabilized.

Habit Forming

No

Therapeutic Class

LUNG SURFACTANTS

SURVANTA INJECTION 8ML Substitute

Substitutes safety advice

Product Substitutes

Author Details

Bayyarapu Mahesh KumarDoctor badge

Written By

Bayyarapu Mahesh Kumar

M Pharmacy

Santoshini Reddy GDoctor badge

Reviewed By

Santoshini Reddy G

M Pharmacy

Last Updated

Jul 8, 2025 | 9:50 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

SURVANTA INJECTION 8ML contains Beractant, a natural surfactant that acts similarly to your baby’s surfactant, helping your baby breathe normally. It will help your baby breathe normally until it produces its own surfactant.

No, it is not necessary to use SURVANTA INJECTION 8ML in all premature babies. It should be used only in premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS).

SURVANTA INJECTION 8ML can be used in those whose pregnancy lasted less than 32 weeks, whose infants are in danger of developing RDS and require a tube put into the windpipe for stabilisation, or who have indications of surfactant deficiency.

Disease/Condition Glossary

Respiratory distress syndrome (RDS): RDS is mainly caused when the baby's lungs do not have enough surfactant. The earlier the infant is born, the more probable they may have RDS. Under such conditions, the baby requires extra oxygen, which is done through ventilatory support.

Have a query?

Buy best Respiratory System products by

whatsapp Floating Button